Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers

NCT ID: NCT02989038

Last Updated: 2020-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

182 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-31

Study Completion Date

2019-12-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate reactions to, and choices to self-administer, cigarette smoke with varying nicotine content among low-frequency, non-dependent adolescent/young adult smokers between the ages of 15-25 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will undergo three sessions in which their reactions to fixed doses of smoke from investigational cigarettes with three different nicotine contents (15.8 mg/gram of tobacco, 2.5 mg/g, and .4 mg/g) will be assessed. Following the third fixed-dose session, participants will return to the lab to choose one of the cigarettes to self-administer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nicotine Dependence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NNC, INC, VLNC

Normal Nicotine Content (NNC), Intermediate Nicotine Content (INC), Very Low Nicotine Content (VLNC)

Group Type EXPERIMENTAL

Very Low Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield

Intermediate Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield

Normal Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield

NNC, VLNC, INC

Normal Nicotine Content, Very Low Nicotine Content, Intermediate Nicotine Content

Group Type EXPERIMENTAL

Very Low Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield

Intermediate Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield

Normal Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield

INC, VLNC, NNC

Intermediate Nicotine Content, Very Low Nicotine Content, Normal Nicotine Content

Group Type EXPERIMENTAL

Very Low Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield

Intermediate Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield

Normal Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield

INC, NNC, VLNC

Intermediate Nicotine Content, Normal Nicotine Content, Very Low Nicotine Content

Group Type EXPERIMENTAL

Very Low Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield

Intermediate Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield

Normal Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield

VLNC, NNC, INC

Very Low Nicotine Content, Normal Nicotine Content, Intermediate Nicotine Content

Group Type EXPERIMENTAL

Very Low Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield

Intermediate Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield

Normal Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield

VLNC, INC, NNC

Very Low Nicotine Content, Intermediate Nicotine Content, Normal Nicotine Content

Group Type EXPERIMENTAL

Very Low Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield

Intermediate Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield

Normal Nicotine Content Cigarettes

Intervention Type OTHER

cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Very Low Nicotine Content Cigarettes

cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield

Intervention Type OTHER

Intermediate Nicotine Content Cigarettes

cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield

Intervention Type OTHER

Normal Nicotine Content Cigarettes

cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Tobacco Cigarettes Tobacco Cigarettes Tobacco Cigarettes

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* generally healthy
* between the ages of 15-25
* use nicotine or tobacco products between 1-15 days/month for at least 6 months
* smokes at least 5 cigarettes/month
* no unstable or significant medical or psychiatric conditions
* breath alcohol value=0.000
* able to provide contact information for two individuals who can corroborate smoking status

Exclusion Criteria

* use of illegal drugs as measured by urine drug screen (excluding THC)
* serious quit attempt in the past 3 months
* plans to quit smoking in the next 2 months
* current use of nicotine replacement therapy or other tobacco cessation products
* inability to attend all required experimental sessions
* blood pressure \>160/100 mmHg
* pregnant, trying to become pregnant, or breastfeeding
Minimum Eligible Age

15 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Drug Abuse (NIDA)

NIH

Sponsor Role collaborator

Duke University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Francis J McClernon, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Duke University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Duke University Medical Center

Durham, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01DA042532

Identifier Type: NIH

Identifier Source: secondary_id

View Link

Pro00075882

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Early Tobacco Abstinence - 5
NCT00224965 TERMINATED PHASE1
Mobile Sensing of Smoking Behavior
NCT02116283 COMPLETED NA
Extended Cessation Treatment for Teen Smokers
NCT00459953 COMPLETED PHASE2/PHASE3